Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An
[3H]ABP688
autoradiography
hippocampus
mGluR5
temporal lobe epilepsy
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
03
2022
accepted:
02
06
2022
entrez:
8
8
2022
pubmed:
9
8
2022
medline:
9
8
2022
Statut:
epublish
Résumé
Abnormalities in the expression of metabotropic glutamate receptor type 5 (mGluR5) have been observed in the hippocampus of patients with drug-resistant mesial Temporal Lobe Epilepsy (mTLE).
Identifiants
pubmed: 35937057
doi: 10.3389/fneur.2022.888479
pmc: PMC9355376
doi:
Types de publication
Journal Article
Langues
eng
Pagination
888479Informations de copyright
Copyright © 2022 Zimmermann, Minuzzi, Aliaga Aliaga, Guiot, Hall, Soucy, Massarweh, El Mestikawy, Rosa-Neto and Kobayashi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Schizophr Res. 2014 Sep;158(1-3):270-1
pubmed: 25043265
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16342-7
pubmed: 22988116
Nat Commun. 2016 Feb 03;7:10604
pubmed: 26837579
Neurochem Res. 2014 Oct;39(10):1862-75
pubmed: 24493625
J Neurophysiol. 2002 Mar;87(3):1395-403
pubmed: 11877514
J Cereb Blood Flow Metab. 2015 Jul;35(7):1169-74
pubmed: 25806702
J Biol Chem. 2009 Dec 18;284(51):35827-38
pubmed: 19840937
Brain. 2006 Jan;129(Pt 1):96-107
pubmed: 16311265
Neurosciences (Riyadh). 2011 Jan;16(1):3-9
pubmed: 21206438
Neurology. 2008 Mar 18;70(12):964-8
pubmed: 18347319
Biochim Biophys Acta. 2012 Apr;1818(4):974-83
pubmed: 22155642
Methods Cell Biol. 2013;113:81-105
pubmed: 23317899
J Biol Chem. 2012 Feb 17;287(8):5412-25
pubmed: 22179607
J Neurosci. 2007 Jul 18;27(29):7696-704
pubmed: 17634364
Nature. 2014 Jul 31;511(7511):557-62
pubmed: 25042998
Neuroscientist. 2001 Aug;7(4):340-52
pubmed: 11488399
Cold Spring Harb Perspect Med. 2015 Jun 01;5(6):
pubmed: 26033084
Biol Psychiatry. 2007 Oct 1;62(7):747-55
pubmed: 17531207
J Nucl Med. 2006 Apr;47(4):698-705
pubmed: 16595505
Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):105-16
pubmed: 9037524
Curr Opin Pharmacol. 2015 Feb;20:95-101
pubmed: 25529199
Bioorg Med Chem. 2007 Jan 15;15(2):903-14
pubmed: 17110115
Nat Neurosci. 2015 Mar;18(3):367-72
pubmed: 25710839
J Nucl Med. 2007 Jul;48(7):1207-15
pubmed: 17574984
Cereb Cortex. 2016 Oct 17;26(11):4170-4179
pubmed: 27578494
PLoS One. 2014 Mar 24;9(3):e92765
pubmed: 24663806
Front Neuroanat. 2015 Mar 05;9:23
pubmed: 25798091
Annu Rev Pharmacol Toxicol. 2010;50:295-322
pubmed: 20055706
Hippocampus. 2013 Dec;23(12):1212-30
pubmed: 23804486
J Neurocytol. 2001 May;30(5):403-11
pubmed: 11951051
Front Pharmacol. 2012 Nov 01;3:189
pubmed: 23125836
J Neurophysiol. 2002 Jan;87(1):621-5
pubmed: 11784776
Epilepsy Curr. 2005 May-Jun;5(3):107-12
pubmed: 16145617
Brain Res Brain Res Rev. 1999 Jan;29(1):83-120
pubmed: 9974152
Epilepsy Res. 2012 Sep;101(3):253-60
pubmed: 22591751
J Biol Chem. 2000 Oct 27;275(43):33750-8
pubmed: 10934211
Ann Neurol. 2019 Feb;85(2):218-228
pubmed: 30597619
J Neurosci. 2014 Mar 26;34(13):4589-98
pubmed: 24672004